The $120 billion company has added a weight-loss drug to its mix of bargain healthcare treatments. San Francisco-based online healthcare platform Hims & Hers is disrupting a new healthcare category: The company just rolled out a bargain semaglutide medication that could compete with Ozempic. The Hims ...
Business Magazine
Author's Latest Articles
-
Second Mouse.AI
-
Evolution May Be Purposeful And It’s Freaking Scientists Out
-
Jon Stewart Goes Into More Detail About Apple Exit and Reveals Execs’ Concerns: ‘They Didn’t Censor Me,’ but ‘Our Aims Don’t Align in Any Way’
-
Supreme Court’s Bump Stock Ruling Is Dystopian Nonsense
COMMUNITY BUSINESS
TOP MEMBERS
-
worldwide
1243760 pt -
Martin Zwilling
766659 pt -
trendmarketers
737838 pt -
itzmealie
600344 pt